| Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments MK Gandhi, R Khanna The Lancet infectious diseases 4 (12), 725-738, 2004 | 841 | 2004 |
| Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial T Haque, GM Wilkie, MM Jones, CD Higgins, G Urquhart, P Wingate, ... Blood, The Journal of the American Society of Hematology 110 (4), 1123-1131, 2007 | 726 | 2007 |
| Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing DM Kurtz, MR Green, SV Bratman, F Scherer, CL Liu, CA Kunder, ... Blood, The Journal of the American Society of Hematology 125 (24), 3679-3687, 2015 | 338 | 2015 |
| Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen–specific CD8+ T-cell function in Hodgkin lymphoma patients MK Gandhi, E Lambley, J Duraiswamy, U Dua, C Smith, S Elliott, D Gill, ... Blood 108 (7), 2280-2289, 2006 | 299 | 2006 |
| Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL F Vari, D Arpon, C Keane, MS Hertzberg, D Talaulikar, S Jain, Q Cui, ... Blood, The Journal of the American Society of Hematology 131 (16), 1809-1819, 2018 | 296 | 2018 |
| Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T … MR Wills, G Okecha, MP Weekes, MK Gandhi, PJG Sissons, ... The Journal of Immunology 168 (11), 5455-5464, 2002 | 279 | 2002 |
| Epstein–Barr virus‐associated Hodgkin's lymphoma MK Gandhi, JT Tellam, R Khanna British journal of haematology 125 (3), 267-281, 2004 | 222 | 2004 |
| Immunodeficiency-associated lymphomas H Tran, J Nourse, S Hall, M Green, L Griffiths, MK Gandhi Blood reviews 22 (5), 261-281, 2008 | 203 | 2008 |
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors RE White, PC Rämer, KN Naresh, S Meixlsperger, L Pinaud, C Rooney, ... The Journal of clinical investigation 122 (4), 2012 | 189 | 2012 |
| Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era AM Evens, S Choquet, AR Kroll-Desrosiers, D Jagadeesh, SM Smith, ... American Journal of Transplantation 13 (6), 1512-1522, 2013 | 177 | 2013 |
| Galectin-1 mediated suppression of Epstein-Barr virus–specific T-cell immunity in classic Hodgkin lymphoma MK Gandhi, G Moll, C Smith, U Dua, E Lambley, O Ramuz, D Gill, ... Blood, The Journal of the American Society of Hematology 110 (4), 1326-1329, 2007 | 175 | 2007 |
| Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker AAI Sina, LG Carrascosa, Z Liang, YS Grewal, A Wardiana, MJA Shiddiky, ... Nature communications 9 (1), 4915, 2018 | 166 | 2018 |
| Plasma microRNA are disease response biomarkers in classical Hodgkin lymphoma K Jones, JP Nourse, C Keane, A Bhatnagar, MK Gandhi Clinical cancer research 20 (1), 253-264, 2014 | 154 | 2014 |
| Epstein–Barr virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy JP Nourse, K Jones, MK Gandhi American Journal of Transplantation 11 (5), 888-895, 2011 | 154 | 2011 |
| Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma MK Gandhi, E Lambley, J Burrows, U Dua, S Elliott, PJ Shaw, HM Prince, ... Clinical Cancer Research 12 (2), 460-464, 2006 | 144 | 2006 |
| Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma K Jones, F Vari, C Keane, P Crooks, JP Nourse, LA Seymour, D Gottlieb, ... Clinical cancer research 19 (3), 731-742, 2013 | 115 | 2013 |
| Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ... Journal of Clinical Oncology 37 (34), 3300, 2019 | 112 | 2019 |
| CD4+ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy C Keane, D Gill, F Vari, D Cross, L Griffiths, M Gandhi American journal of hematology 88 (4), 273-276, 2013 | 94 | 2013 |
| Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment T Kobayashi, PY Lam, H Jiang, K Bednarska, R Gloury, V Murigneux, ... Blood, The Journal of the American Society of Hematology 136 (26), 3004-3017, 2020 | 88 | 2020 |
| Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions C Lees, C Keane, MK Gandhi, J Gunawardana British journal of haematology 185 (1), 25-41, 2019 | 87 | 2019 |
colm keaneLymphoma Research Lab, University of Queensland Diamantina InstituteVerified email at uq.edu.au
